Erlotinib hydrochlo...

Erlotinib hydrochloride

Erlotinib hydrochloride

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity: 99%
  • Payment Terms : L/C,T/T

Keywords

4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride (9CI) 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride CP358774

Quick Details

  • Appearance:white powder
  • Application:Second - or third-line treatment of locally advanced or metastatic non-small cell lung cancer and treatment of pancreatic cancer
  • PackAge:fiber can
  • ProductionCapacity:200|Kilogram|Year
  • Storage:store at 2-8℃
  • Transportation:air transport

Superiority:

The quality of our products is guaranteed and the price is low!

Details:

CAS number :183319-69-9
English name :Erlotinibhydrochloride English alias :ERLOTINIBHCL; Tarceva; ErL; Erlotinib,HydrochlorideSalt; CS-491; OSI774; RG-1415; CP358774; NSC718781; ChemicalbookRO-0508231API
Molecular formula :C22H24ClN3O4
Molecular weight :429.9

Chemical properties Melting point :223-225°C
Storage conditions: Inertatmosphere Storeinfreezer, under - 20 ° C
Solubility SolubleinDMSO(upto18mg/mlwithwarming)
Acidity factor (pKa):pKa(25°):5.Chemicalbook42 Form :Yellowpowder.
Color :Whiteoroff-white

Stability Stablefor1yearfromdateofpurchaseassupplied. SolutionsinDMSOmaybestoredat - 20 ° forupto3months.

Erlotinib hydrochloride is a small molecule epidermal growth factor receptor tyrosine kinase reversible inhibitor, mainly used in the treatment of locally advanced or metastatic non-small cell lung cancer second or third line treatment and pancreatic cancer.

Erlotinib targets the epidermal growth factor receptor subtype (EGFR-TK) that reversibly and selectively acts on tyrosine kinase receptors. Its mechanism of action is to compete with substrates in the cell, inhibit EGFR-TK phosphorylation, block tumor cell signaling, inhibit tumor cell growth, and induce apoptosis. Clinical studies have shown that the drug has an inhibitory effect on a variety of tumors. Compared with traditional chemotherapy drugs, it has the advantages of less adverse reactions, better safety and tolerance.

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View